mRNA-5671/V941

mRNA-5671 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-5671/V941, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) [Phase 1]